Store unopened vials at -20C, protected from light and moisture
When evaluated realistically, IGF-1 LR3 before and after transformations represent accumulated effort, optimized recovery, and structured lifestyle management rather than sudden change
A 2021 retrospective observational study cited in the PMC literature directly compared BPC-157 alone versus BPC-157 combined with TB-500 in a knee injection protocol and found the combination to be associated with improved outcomes providing the first head-to-head comparative observation of the two compounds used together versus independently
IGF-1 LR3 supplied as lyophilized powder is typically reconstituted at 1 mg/mL concentration, yielding 100 mcg per 0.1 mL injection volume
For more on the benefits of peptides, visit this article on peptide applications
The titration schedule used in clinical trials (slow, stepwise dose increases over multiple weeks) is specifically designed to minimize the intensity of these early side effects